Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
PMI Biopharma Solutions and Nashville Biosciences Announce Strategic Alliance to Combine Comprehensive Drug Discovery Support
Saturday, March 07, 2020PMI Biopharma Solutions a provider of research pharmaceutical development and earlyphase clinical manufacturing services and Nashville Biosciences a clinicalgenomic and bioinformatics company today announced a strategic collaboration to leverage both...
TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug Administration for the Treatment of Follicular Lymphoma
Friday, March 06, 2020TG Therapeutics Inc announced that the US Food and Drug Administration FDA granted orphan drug designation to umbralisib the Companys investigational dual inhibitor of PIKdelta and CKepsilon for the treatment of patients with follicular lymphoma FL
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Rare Pediatric Disease Designation for Trofinetide for the Treatment of Rett Syndrome
Friday, March 06, 2020CADIA Pharmaceuticals Inc and Neuren Pharmaceuticals Limited announced today that the US Food and Drug Administration FDA granted Rare Pediatric Disease RPD designation to trofinetide for the treatment of Rett syndrome a serious and rare neurological...
Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19
Thursday, March 05, 2020Vir Biotechnology Inc and Alnylam Pharmaceuticals Incannounced an expansion of their existing collaboration to include the development and commercialization of RNAi therapeutics targeting SARSCoV the virus that causes the disease COVID Under the agre...
Alopexx Oncology Announces Licensing Agreement with Beijing Shenogen Pharma Group for Development and Commercialization of Novel Immunocytokine
Thursday, March 05, 2020Alopexx Oncology LLC announced that it has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DILeuIL in China and other parts of Asia Alopexx will receive an upfront payment various developme...
Singapore-born digital therapeutics company inks deal with Hong Kong govt to fight COVID-19
Wednesday, March 04, 2020As the novel coronavirus COVID continues to spread a Singapore born Bostonbased digital therapeutics company has inked a deal with The University of Hong Kong and Hong Kongs Department of Health to leverage its cuttingedge wearable technology and AIp...
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Rare Pediatric Disease Designation for Trofinetide for the Treatment of Rett Syndrome
Wednesday, March 04, 2020ACADIA Pharmaceuticals Inc and Neuren Pharmaceuticals Limited announced that the US Food and Drug Administration FDA granted Rare Pediatric Disease RPD designation to trofinetide for the treatment of Rett syndrome a serious and rare neurological diso...
Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform
Wednesday, March 04, 2020Iktos a company specialized in artificial intelligence AI for novel drug design and SRI International SRI a research center headquartered in Menlo Park California today announced that the companies have entered into a collaboration agreement designed...
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Tuesday, March 03, 2020Samsung Biologics and STCube announced a strategic development and manufacturing service agreement for STT antibody an anticancer drug candidateUnder the agreement Samsung Biologics will offer a wide range of services from cell line development proce...
CYTOO and AskBio Enter Research Agreement to Screen Gene Therapy Candidates for Rare Muscle Disorder
Tuesday, March 03, 2020CYTOO a leading drug discovery company on muscle disorders today announced that it has entered into a research collaboration aimed at selecting a gene therapy candidate for a rare muscle disorder with Asklepios BioPharmaceutical Inc AskBio a clinical...
